Morphine Sulfate
NDC 63629-4484, Morphine Sulfate, tablet, film coated, extended release, from Bryant Ranch Prepack.
- Product NDC
- 63629-4484
- Status
- Listed
- Labeler
- Bryant Ranch Prepack
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA074862
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/63629-4484 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MORPHINE SULFATE30 mg/1
Pharmacologic classes
Full Opioid Agonists [MoA]; Opioid Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63629-4484-0 | 63629448400 | 40 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-0) |
| 63629-4484-1 | 63629448401 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-1) |
| 63629-4484-2 | 63629448402 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-2) |
| 63629-4484-3 | 63629448403 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-3) |
| 63629-4484-4 | 63629448404 | 120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-4) |
| 63629-4484-5 | 63629448405 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-5) |
| 63629-4484-6 | 63629448406 | 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-6) |
| 63629-4484-7 | 63629448407 | 15 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-7) |
| 63629-4484-8 | 63629448408 | 20 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-8) |
| 63629-4484-9 | 63629448409 | 26 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (63629-4484-9) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/cc3b491c-a206-3027-54f0-f87c0dd40a7f
Use it
Look up 63629-4484 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63629-4484 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63629-4484. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.